Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.23750/abm.v91i2.9639 http://scihub22266oqcxt.onion/10.23750/abm.v91i2.9639 32420936!7569629!32420936     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Acta+Biomed 2020 ; 91 (2): 118-136 Nephropedia Template TP {{tp|p=32420936|t=2020. Treatments for COVID-19: emerging drugs against the coronavirus |pdf=|usr=}}{{32420936}} gab.com Text Treatments for COVID-19: emerging drugs against the coronavirus JO: Acta Biomed http://www.kidney.de/pget.php?&tw=1&pmid=32420936 #FOAvip The Coronavirus disease 19 (COVID-19) outbreak has been recognized as a global threat to public health. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and no effective therapies currently exist against this novel viral agent. Along with extensive public health measures, an unprecedented global effort in identifying effective drugs for the treatment is being implemented. Potential drug targets are emerging as the result of a fast-evolving understanding of SARS-CoV-2 virology, host response to the infection, and clinical course of the disease. This brief review focuses on the latest and most promising pharmacological treatments against COVID-19 currently under investigation and discuss their potential use based on either documented efficacy in similar viral infections, or their activity against inflammatory syndromes. Ongoing clinical trials are also emphasized. Twit Text FOAVip Treatments for COVID-19: emerging drugs against the coronavirus ????Acta Biomed http://www.kidney.de/pget.php?&tw=1&pmid=32420936 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32420936 #FOAvip English Wikipedia <ref>{{Cite pmid|32420936}}</ref> Treatments for COVID-19: emerging drugs against the coronavirus #MMPMID32420936 Poti F; Pozzoli C; Adami M; Poli E; Costa LG Acta Biomed 2020[May]; 91 (2): 118-136 PMID32420936show ga The Coronavirus disease 19 (COVID-19) outbreak has been recognized as a global threat to public health. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and no effective therapies currently exist against this novel viral agent. Along with extensive public health measures, an unprecedented global effort in identifying effective drugs for the treatment is being implemented. Potential drug targets are emerging as the result of a fast-evolving understanding of SARS-CoV-2 virology, host response to the infection, and clinical course of the disease. This brief review focuses on the latest and most promising pharmacological treatments against COVID-19 currently under investigation and discuss their potential use based on either documented efficacy in similar viral infections, or their activity against inflammatory syndromes. Ongoing clinical trials are also emphasized. |Anticoagulants/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus/*drug effects[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Coronavirus Infections/*drug therapy[MESH] |Humans[MESH] |Inflammation/drug therapy[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy[MESH]Treatments for COVID-19: emerging drugs against the coronavirus (epmc).pdf DeepDyve Pubget Overpricing